Literature DB >> 19499579

Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalities.

Göran Carlsson1, Göran Elinder, Helena Malmgren, Alicja Trebinska, Ewa Grzybowska, Niklas Dahl, Magnus Nordenskjöld, Bengt Fadeel.   

Abstract

Kostmann disease or severe congenital neutropenia (SCN) is an autosomal recessive disorder of neutrophil production. Homozygous HAX1 mutations were recently identified in SCN patients belonging to the original family in northern Sweden described by Kostmann. Moreover, recent studies have suggested an association between neurological dysfunction and HAX1 deficiency. Here we describe a patient with a compound heterozygous HAX1 mutation consisting of a nonsense mutation (c.568C > T, p.Glu190X) and a frame-shift mutation (c.91delG, p.Glu31LysfsX54) resulting in a premature stop codon. The patient has a history of neutropenia and a propensity for infections, but has shown no signs of neurodevelopmental abnormalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499579     DOI: 10.1002/pbc.22131

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  Specific alterations of the HtrA2/HAX-1 ratio in the penumbra upon focal cerebral ischemia in mice.

Authors:  A Rami; A Langhagen
Journal:  Neurochem Res       Date:  2011-11-06       Impact factor: 3.996

2.  Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia.

Authors:  Marina Lanciotti; Stefania Indaco; Sonia Bonanomi; Tiziana Coliva; Elena Mastrodicasa; Gianluca Caridi; Michaela Calvillo; Carlo Dufour
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

3.  A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmental abnormalities.

Authors:  Sheng-Li Xue; Jin-Li Li; Jing-Ying Zou; Jian Su; Su-Ning Chen; De-Pei Wu
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

4.  A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations.

Authors:  Muhammad Faiyaz-Ul-Haque; Abdullah Al-Jefri; Fouad Al-Dayel; Jalaluddin A K M Bhuiyan; Hala A Abalkhail; Randa Al-Nounou; Ahmed Al-Abdullatif; Monogaran S Pulicat; Ameera Gaafar; Ayodele A Alaiya; Iskra Peltekova; Syed H E Zaidi
Journal:  Eur J Pediatr       Date:  2010-02-25       Impact factor: 3.183

5.  Alterations in the expression of the anti-apoptotic factor HAX-1 upon seizures-induced hippocampal injury in the neonatal rat brain.

Authors:  A Rami; M Kim; J Niquet; A Langhagen
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

6.  Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia.

Authors:  Ying Ye; Göran Carlsson; Biniyam Wondimu; Annika Fahlén; Jenny Karlsson-Sjöberg; Mats Andersson; Lars Engstrand; Tülay Yucel-Lindberg; Thomas Modéer; Katrin Pütsep
Journal:  J Clin Immunol       Date:  2011-07-29       Impact factor: 8.317

7.  Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.

Authors:  Piers Blombery; Lucy Fox; Georgina L Ryland; Ella R Thompson; Jennifer Lickiss; Michelle McBean; Satwica Yerneni; David Hughes; Anthea Greenway; Francoise Mechinaud; Erica M Wood; Graham J Lieschke; Jeff Szer; Pasquale Barbaro; John Roy; Joel Wight; Elly Lynch; Melissa Martyn; Clara Gaff; David Ritchie
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941

8.  Immunoblotting validation of research antibodies generated against HS1-associated protein X-1 in the human neutrophil model cell line PLB-985.

Authors:  Peter Cavnar; Kristina Inman
Journal:  F1000Res       Date:  2015-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.